Kazlouskaya V

Total Page:16

File Type:pdf, Size:1020Kb

Kazlouskaya V MINISTRY OF HEALTH OF REPUBLIC OF BELARUS GOMEL STATE MEDICAL UNIVERSITY V. V. Kazlouskaya SELECTED LECTURES ON DERMATOLOGY Manual for foreign medical students Gomel GSMU 2008 УДК 616.5 (075.8)=20 ББК 55.8 К 59 Рецензеты: заведующий кафедрой дерматовенерологии УО «Витебский государственный медицинский университет», доктор медицинских наук, профессор В. П. Адаскевич; заведующий кафедрой поликлинической терапии и общеврачебной практики с курсом дерматовенерологии УО «Гомельский государственный медицинский университет», кандидат медицинских наук, доцент Э. Н. Платошкин. Козловская, В. В. К 59 Курс лекций по дерматологии: учеб.-метод. пособие для студентов- медиков = Selected Lectures on Dermatology: manual for foreign medical students / В. В. Козловская. — Гомель: Учреждение образования «Го- мельский государственный медицинский университет», 2008. — 160 с. ISBN 978-985-506-210-4 Учебно-методическое пособие «Selected Lectures on Dermatology» представляет собой курс лекций по дерматологии, предназначенный для иностранных студентов 3 курса, обучающихся на английском языке. Лекции составлены в соответствии с типовой учебной программой и содержат основные разделы цикла дерматология. Утверждено и рекомендовано к изданию Центральным учебным научно- методическим советом учреждения образования «Гомельский государственный медицинский университет» 20 ноября 2008 г., протокол № 11. УДК 616.5 (075.8) ББК 55.8 ISBN 978-985-506-210-4 © Учреждение образования «Гомельский государственный медицинский университет», 2008 2 Abbreviations Used in the Book AA — alopecia areata HPV — human papiloma virus ACD — allergic contact dermatitis HSV — herpes simplex virus AD — atopic dermatitis IL — interminate leprosy AGA — allergic granulomatous angiitis JEB — junctional epidermolysis AIDS — aquired immunodeficiency bullosa syndrome KS — sarcoma Kaposi ANA — anti-nuclear antibodies LCL — local cutaneous leishmaniasis ANCA — antineutrophil cytoplasmic LDH — lactate dehydrogenase antibodies LE — lupus erythematosus AST — aspartate aminotransferase LGV — lymphogranulomatosis ASO — anti streptococcal O antigen venereal BBL — borderline borderline leprosy LL — lepromatous leprosy BCIE — bullous congenital LP – lichen planus ichthyosiform erythroderma LR — leishmaniasis recidivans BL — lorderline lepromatous leprosy MF — mycosis fungoides BTL — borderline tuberculoid leprosy NBCIE — nonbullous congenital CLE — cutaneous lupus erythematosus ichthyosiform erythroderma CRP — C-reactive protein NSAIDs — non steroid anti- CSF — cerebral spinal fluid inflammatory drugs CSVV — cutaneus small vessel OM — onichomycosis vasculitis PCAS — perifolliculitis capitis CTCL — cutaneous T-cell lymphoma abscedens et suffodiens DCL — dissiminative cutaneous PF — pemphigus foliaceus leishmaniasis PKADL — Post-Kala-Azar DDS — dapsone Dermal leishmaniasis DEB — dystrophic epidermolysis PN — polyarteritis nodosa bullosa PUVA — psoralen plus ultraviolet DH — dermatitis herpetiformic During A therapy DLST — drug lymphocyte stimulating PV — pemphigus vulgaris test RA — rheumatoid arthritis DM — dermatopmyositis SJS — Stevens – Jonson syndrome DNA — deoxyribonuclease SLE — systemic lupus DPCP — diphenylcyclopropenone erythematosus EB — epidermolysis bullosa SS — Sezary syndrome EED — erythema elevatum diutinum TA — temporal arteriitis EM — erythema mygrans TAO — tromboangiitis obliterans EMM — erythema multiforme TEN — toxic epidermolysis ESR — erythrocyte sedimentation rate TL — tuberculoid leprosy GABHS — group of B hemolytic TSEB — total skin electron beam streptococcus VL — visceral leishmaniasis VZV — varicella zoster virus 3 Content Lecture 1. Structure and Functions of the Skin. Main Pathomorphological Processes in the Skin. Principles of the Therapy of Diseases of the Skin................................................................................7 Structure of the Skin ..............................................................................................................................7 Epidermis ........................................................................................................................................7 Dermo-epidermal junction .............................................................................................................8 Derma..............................................................................................................................................9 The subcutaneous tissue (subdermal fatty tissue) .........................................................................9 Cutaneous sensory system ..............................................................................................................9 Cutaneous vessel system ...............................................................................................................10 Sebaceous glands..........................................................................................................................12 Sweet glands..................................................................................................................................13 Nails ..............................................................................................................................................14 Functions of the skin........................................................................................................................17 Dermapathological processes..........................................................................................................17 Principles of the Therapy of Diseases of the Skin. ........................................................................20 Systemic Therapy..........................................................................................................................21 Phototherapy.................................................................................................................................22 Photochemotherapy (PUVA)........................................................................................................22 Cryotherapy...................................................................................................................................22 Laser (Light Amplification by Stimulated Emission of Radiation) ............................................22 Lecture 2. Observation of the Skin Patient (scheme of the case history) ........................................23 Lecture 3. Bacterial Infections of the Skin (Pyodermas). .................................................................32 Staphylococcal Infections ..................................................................................................................32 Folliculitis .....................................................................................................................................32 Boils (Furuncles)..........................................................................................................................33 Hydradenitis Suppurativa.............................................................................................................33 Carbuncles ....................................................................................................................................34 Paronychial Infections .................................................................................................................34 Staphylococcal Scalded Skin Syndrome (Ritter-Lyell Syndrome) ..............................................35 Streptococcal Infections...................................................................................................................36 Impetigo.........................................................................................................................................36 Ecthyma.........................................................................................................................................37 Impetigo angularis (perleche, cheilitis angularis, stomatitis angularis, angular cheilitis) .......37 Pyoderma gangrenosum...............................................................................................................37 Pityriasis alba................................................................................................................................38 Perifolliculitis Capitis Abscedens et Suffodiens (PCAS).............................................................38 Lecture 4. Parasitic Diseases of the Skin............................................................................................40 Scabies...............................................................................................................................................40 Pediculosis.........................................................................................................................................43 Lecture 5. Mycobacterial Infections of the Skin................................................................................45 Tuberculosis of the skin...................................................................................................................45 Lupus vulgaris ..............................................................................................................................46 TB verrucosa cutis ........................................................................................................................47 Scrofuloderma...............................................................................................................................47
Recommended publications
  • Pathological Investigation of Rosacea with Particular Regard Of
    CORE Metadata, citation and similar papers at core.ac.uk Provided by White Rose E-theses Online A Clinico-Pathological Investigation of Rosacea with Particular Regard to Systemic Diseases Dr. Mustafa Hassan Marai Submitted in accordance with the requirements for the degree of Doctor of Medicine The University of Leeds School of Medicine May 2015 “I can confirm that the work submitted is my own and that appropriate credit has been given where reference has been made to the work of others” “This copy has been supplied on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement” May 2015 The University of Leeds Dr. Mustafa Hassan Marai “The right of Dr Mustafa Hassan Marai to be identified as Author of this work has been asserted by him in accordance with the Copyright, Designs and Patents Act 1988” Acknowledgement Firstly, I would like to thank all the patients who participate in my rosacea study, giving their time and providing me with all of the important information about their disease. This is helped me to collect all of my study data which resulted in my important outcome of my study. Secondly, I would like to thank my supervisor Dr Mark Goodfield, consultant Dermatologist, for his continuous support and help through out my research study. His flexibility, understanding and his quick response to my enquiries always helped me to relive my stress and give me more strength to solve the difficulties during my research. Also, I would like to thank Dr Elizabeth Hensor, Data Analyst at Leeds Institute of Molecular Medicine, Section of Musculoskeletal Medicine, University of Leeds for her understanding the purpose of my study and her help in analysing my study data.
    [Show full text]
  • Pathogenesis of Rosacea Anetta E
    REVIEW Pathogenesis of Rosacea Anetta E. Reszko, MD, PhD; Richard D. Granstein, MD Rosacea is a chronic, common skin disorder whose pathogenesis is incompletely understood. An inter- play of multiple factors, including genetic predisposition and environmental, neurogenic, and microbial factors, may be involved in the disease process. Rosacea subtypes, identified in the recently published standard classification system by the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea, may in fact represent different disease processes, and identifying subtypes may allow investigators to pursue more precisely focused studies. New developments in molecular biology and genetics hold promise for elucidating the interplay of the multiple factors involved in the pathogen- esis of rosacea, as well as providing the bases for potential new therapies. osacea is a common, chronic skin disorder and secondary features needed for the clinical diagnosis primarily affecting the central and con- of rosacea. Primary features include flushing (transient vex areas of COSthe face. The nose, cheeks, DERM erythema), persistent erythema, papules and pustules, chin, forehead, and glabella are the most and telangiectasias. Secondary features include burn- frequently affected sites. Less commonly ing and stinging, skin dryness, plaque formation, dry affectedR sites include the infraorbital, submental, and ret- appearance, edema, ocular symptoms, extrafacial mani- roauricular areas, the V-shaped area of the chest, and the festations, and phymatous changes. One or more of the neck, the back, and theDo scalp. Notprimary Copy features is needed for diagnosis.1 The disease has a variety of clinical manifestations, Several authors have theorized that rosacea progresses including flushing, persistent erythema, telangiecta- from one stage to another.2-4 However, recent data, sias, papules, pustules, and tissue and sebaceous gland including data on therapeutic modalities of various sub- hyperplasia.
    [Show full text]
  • Richtlijn Acneïforme Dermatosen
    Richtlijn Acneïforme dermatosen Richtlijn: Acneïforme dermatosen Colofon Richtlijn Acneïforme dermatosen © 2010, Nederlandse Vereniging voor Dermatologie en Venereologie (NVDV) Postbus 8552, 3503 RN Utrecht Telefoon: 030-2823180 E-mail: [email protected] Alle rechten voorbehouden. Niets uit deze uitgave mag worden verveelvoudigd of openbaar worden gemaakt, in enige vorm of op enige wijze, zonder voorafgaande schriftelijke toestemming van de Nederlandse Vereniging voor Dermatologie en Venereologie. Deze richtlijn is opgesteld door een daartoe geïnstalleerde werkgroep van de Nederlandse Vereniging voor Dermatologie en Venereologie. De richtlijn is vervolgens vastgesteld in de algemene ledenvergadering. De richtlijn vertegenwoordigt de geldende professionele standaard ten tijde van de opstelling van de richtlijn. De richtlijn bevat aanbevelingen van algemene aard. Het is mogelijk dat deze aanbevelingen in een individueel geval niet van toepassing zijn. De toepasbaarheid en de toepassing van de richtlijnen in de praktijk is de verantwoordelijkheid van de behandelend arts. Er kunnen zich feiten of omstandigheden voordoen waardoor het wenselijk is dat in het belang van de patiënt van de richtlijn wordt afgeweken. 1 Versie 18-06-2010 WERKGROEP Prof. dr. P.C.M. van de Kerkhof, dermatoloog, voorzitter werkgroep Mw. J.A. Boer, huidtherapeut Drs. R.J. Borgonjen, ondersteuner werkgroep Dr .J.J.E. van Everdingen, dermatoloog Mw. M.E.M. Janssen, huidtherapeut Drs. M. Kerzman, NHG/huisarts Dr. J. de Korte, dermatopsycholoog Drs. M.F.E. Leenarts, dermatoloog i.o. Drs. M.M.D. van der Linden, dermatoloog Dr. J.R. Mekkes, dermatoloog Drs. J.E. Mooij, promovendus dermatologie Drs. L. van ’t Oost, dermatoloog i.o. Dr. V. Sigurdsson, dermatoloog Mw. C. Swinkels, hidradenitis patiënten vereniging/patiëntvertegenwoordiger Drs.
    [Show full text]
  • (2006.01) Published: A61K9/08
    ) ( (51) International Patent Classification: Published: A61K 31/05 (2006.01) A61P 1 7/02 (2006.01) — with international search report (Art. 21(3)) A61K9/08 (2006.01) A61P29/00 (2006.01) A61P 1 7/00 (2006.01) (21) International Application Number: PCT/AU20 19/05005 1 (22) International Filing Date: 24 January 2019 (24.01.2019) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 2018900226 24 January 2018 (24.01.2018) AU 62/621,225 24 January 2018 (24.01.2018) US 2018903600 25 September 2018 (25.09.2018) AU 62/736,052 25 September 2018 (25.09.2018) US (71) Applicant: BOTANIX PHARMACEUTICALS LTD [AU/AU]; 63 Aberdeen Street, Northbridge, Western Aus¬ tralia 6003 (AU). (72) Inventors: CALLAHAN, Matthew; One Kew Place, 150 Rouse Boulevard, Navy Yard Corporate Center, Philadel¬ phia, Pennsylvania 191 12 (US). THURN, Michael; 912 Kangaroobie Road, Kangaroobie, NSW 2800 (AU). (74) Agent: WRAYS PTY LTD; Level 7, 863 Hay Street, Perth, Western Australia 6000 (AU). (81) Designated States (unless otherwise indicated, for every kind of national protection available) : AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Curriculum Vitae Clay J. Cockerell, M.D. Home
    CURRICULUM VITAE CLAY J. COCKERELL, M.D. HOME ADDRESS 4312 Arcady Avenue Dallas, Texas 75205 (214) 522-2610 WORK ADDRESS Cockerell & Associates-Dermpath Diagnostics Dermatopathology Laboratories 2330 Butler Street, Suite 115 Dallas, Texas 75235 Phone: (214) 530-5200, (800) 309-0000 Fax: (214) 530-5232 BIRTH DATE AND PLACE September 16, 1956, Houston, Texas MARITAL STATUS Married - Brenda West Cockerell Two children - Charles West Cockerell & Lillian Allene Cockerell COLLEGE EDUCATION 1974 – 1977 Texas Tech University Majors: Zoology, Microbiology, Chemistry No degree - entered Medical School via Early Decision Program GRADUATE EDUCATION 1977 - 1981 Baylor College of Medicine Degree - M.D. with honors, June 1981 POSTGRADUATE EDUCATION 1981-1982 Internship, Internal Medicine University of Washington Affiliated Hospitals, Seattle, Washington 1982-1985 Residency, Dermatology New York University Medical Center, New York, New York 1984-1985 Chief Resident, Dermatology New York University Medical Center, New York, New York 1985-1986 Fellowship, Dermatopathology New York University Medical Center, New York, New York OTHER TRAINING Sloan-Kettering Memorial Hospital, Pathology New York, New York Part-time clinical observer July 1986 - January 1987 Clay J. Cockerell, M.D. Updated 1/15/2018 Page 2 ACADEMIC APPOINTMENTS University of Texas Southwestern Medical Center Assistant Professor, Dermatology and Pathology, September 1988 - September 1992 Associate Professor, Dermatology and Pathology, September 1992 - September 1993 Clinical Associate Professor,
    [Show full text]
  • Pathological Investigation of Rosacea with Particular Regard Of
    A Clinico-Pathological Investigation of Rosacea with Particular Regard to Systemic Diseases Dr. Mustafa Hassan Marai Submitted in accordance with the requirements for the degree of Doctor of Medicine The University of Leeds School of Medicine May 2015 “I can confirm that the work submitted is my own and that appropriate credit has been given where reference has been made to the work of others” “This copy has been supplied on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement” May 2015 The University of Leeds Dr. Mustafa Hassan Marai “The right of Dr Mustafa Hassan Marai to be identified as Author of this work has been asserted by him in accordance with the Copyright, Designs and Patents Act 1988” Acknowledgement Firstly, I would like to thank all the patients who participate in my rosacea study, giving their time and providing me with all of the important information about their disease. This is helped me to collect all of my study data which resulted in my important outcome of my study. Secondly, I would like to thank my supervisor Dr Mark Goodfield, consultant Dermatologist, for his continuous support and help through out my research study. His flexibility, understanding and his quick response to my enquiries always helped me to relive my stress and give me more strength to solve the difficulties during my research. Also, I would like to thank Dr Elizabeth Hensor, Data Analyst at Leeds Institute of Molecular Medicine, Section of Musculoskeletal Medicine, University of Leeds for her understanding the purpose of my study and her help in analysing my study data.
    [Show full text]
  • A Dissertation on CLINICO EPIDEMIOLOGICAL STUDY of FACIAL DERMATOSES AMONG ADULTS
    A Dissertation on CLINICO EPIDEMIOLOGICAL STUDY OF FACIAL DERMATOSES AMONG ADULTS Dissertation submitted to THE TAMILNADU DR.M.G.R. MEDICAL UNIVERSITY CHENNAI-600032 With partial fulfillment of the requirements for the award of M.D.DEGREE IN DERMATOLOGY, VENEREOLOGY AND LEPROLOGY (BRANCH - XX) REG. No. 201730201 COIMBATORE MEDICAL COLLEGE AND HOSPITAL COIMBATORE MAY 2020 DECLARATION I Dr . MANIVANNAN . M solemnly declare that the dissertation entitled “CLINICO EPIDEMIOLOGICAL STUDY OF FACIAL DERMATOSES AMONG ADULTS ” is a bonafide work done by me at Coimbatore Medical College Hospital during the year June 2018 to May 2019 under the guidance & supervision of Dr. M. KARUNAKARAN M.D., (DERM) Professor& Head of Department, Department of Dermatology, Coimbatore Medical College & Hospital. The dissertation is submitted to Dr. MGR Medical University towards partial fulfillment of requirement for the award of MD degree branch XX Dermatology, Venereology and Leprology. PLACE: Dr. MANIVANNAN .M DATE: CERTIFICATE This is to certify that the dissertation entitled “CLINICO EPIDEMIOLOGICAL STUDY OF FACIAL DERMATOSES AMONG ADULTS” is a bonafide original work done by Dr. MANIVANNAN.M. Post graduate student in the Department of Dermatology, Venereology and Leprology, Coimbatore Medical College Hospital, Coimbatore under the guidance of Dr. M. KARUNAKARAN M.D., (DERM), Professor and HOD of Department, Department of Dermatology, Coimbatore Medical College Hospital, Coimbatore in partial fulfillment of the regulations for the Tamilnadu DR.M.G.R Medical University, Chennai towards the award of MD., degree (Branch XX.) in Dermatology, Venereology and Leprology. Date : GUIDE Dr. M. KARUNAKARAN M.D., (DERM) Professor & HOD, Department of Dermatology, Coimbatore Medical College & Hospital. Date : Dr.
    [Show full text]
  • The Great Mimickers of Rosacea
    The Great Mimickers of Rosacea Jeannette Olazagasti, BS; Peter Lynch, MD; Nasim Fazel, MD, DDS Practice Points Rosacea is characterized by frequent flushing; persistent erythema (ie, lasting for at least 3 months); telangiectasia; and interspersed episodes of inflammation with swelling, papules, and pustules. Rosacea is most commonly seen in adults older than 30 years and is considered to have a strong hereditary component, as it is more commonly seen in individuals of Celtic and Northern European descent as well as those with fair skin. Although rosacea is one of the most common Rosacea Characteristics conditions treated by dermatologists, it also is Rosacea is a chroniccopy disorder affecting the central one of the most misunderstood. It is a chronic dis- parts of the face that is characterized by frequent order affecting the central parts of the face and flushing; persistent erythema (ie, lasting for at least is characterized by frequent flushing; persistent 3 months); telangiectasia; and interspersed epi- erythema (ie, lasting for at least 3 months); tel- sodes of inflammation with swelling, papules, and angiectasia; and interspersed episodes of inflam- pustules.not2 It is most commonly seen in adults older mation with swelling, papules, and pustules. than 30 years and is considered to have a strong Understanding the clinical variants and disease hereditary component, as it is more commonly seen course of rosacea is important to differentiateDo in individuals of Celtic and Northern European this entity from other conditions that can mimic descent as well as those with fair skin. Furthermore, rosacea. Herein we present several mimickers of approximately 30% to 40% of patients report a fam- rosacea that physicians should consider when ily member with the condition.2 diagnosing this condition.
    [Show full text]
  • Abscess, 600, 601F, 602 Apocrine Sweat Gland, 14–16
    3038r_ind_1023-1041 4/11/01 2:14 PM Page 1023 INDEX A Allergic phytodermatitis (APD), 26–28, Abscess, 600, 601f, 602 28f–29f apocrine sweat gland, 14–16, 15f, 17f Allopurinol, drug reaction to, 554 tuberculosis, metastatic, 661–662, 664, 666 ALM (acral lentiginous melanoma), 295–296, Acantholytic dermatosis, transient, 112, 113f 297f Acanthosis nigricans (AN), 82–83, 83f Alopecia classification, 82 nonscarring, 928–940 malignant, 82–83, 493, 493f–494f alopecia areata, 928–930, 929f, 931f ACD. See Allergic contact dermatitis alopecia totalis, 928 ACDRs (adverse cutaneous drug reactions). alopecia universalis, 928, 931f See Drug reactions anagen effluvium, 940, 940f ACE (angiotensin-converting enzyme) inhib- androgenetic alopecia, 932–936, 933f, itors, reactions to, 556 935f–936f Acetowhitening, 1015 neoplastica, 482 Acne keloidalis, 941, 945f telogen effluvium, 937–939, 938t–939t, Acne rosacea. See Rosacea 939f Acne vulgaris, 2–6, 3f, 5f, 7f scarring, 941, 942f–945f, 942t acne conglobata, 4 α1 antitrypsin-deficiency panniculitis, 146 acne fulminans, 4 Amiodarone-induced pigmentation, 566, 567f recalcitrant acne, 4 Amoxicillin drug reaction, 554 Acneform drug eruptions, 548 Ampicillin drug reaction, 553f, 554 Acral lentiginous melanoma (ALM), 295–296, Amyloidosis, systemic, 334–336, 335f, 337f 297f acquired, 334–336, 335f, 337f Acrochordon, 209f secondary, 334, 336 Acrodermatitis continua of Hallopeau, 69 AN. See Acanthosis nigricans Acrodermatitis enteropathica, 430–431, 432f Anagen effluvium, 940, 940f Acrosclerosis, 375f Anaphylaxis and anaphylactoid reactions, 547, ACTH-induced pigmentation, 568 556, 558 Actinic keratosis, 217, 219, 220f Angioedema and urticaria, 338–344, 339f, Actinic prurigo, 230, 234 341f–343f, 344t, 345f Acute febrile neutrophilic dermatosis. See drug reaction, 547, 556–558, 559f Sweet’s syndrome urticaria perstans, 393–394, 394f Acute retroviral syndrome (ARS), 912–915, urticarial vasculitis, 393–394, 394f 915f, 915t Angiokeratoma, 183f AD.
    [Show full text]
  • Otophyma: About a Case
    ACNE, ROSACEA, AND RELATED DISORDERS (INCLUDING HIDRADENITIS SUPPURATIVA) OTOPHYMA: ABOUT A CASE N Maya (1) - E Tababa (1) - Na Vashi (1) Boston University School Of Medicine, Department Of Dermatology, Boston, United States (1) Background: Phyma, a slowly progressive and disfiguring disorder of the face and ears, is generally considered to be an advanced form of rosacea. Interestingly, it may occur in patients with no other signs or symptoms of rosacea. It is caused by sebaceous gland hyperplasia and hypertrophy with surrounding fibrous tissue proliferation. Phyma typically affects the nose (rhinophyma); however, equivalent presentations can occur on the chin (gnatophyma), forehead (metophyma), ears (otophyma), and eyelids (blepharophyma). Although rhinophyma is ubiquitously seen in clinical practice, otophyma (rosaceous lymphedema of the ear) is much more rare and uncommonly reported in the literature. It presents as either unilateral or bilateral edematous ear involvement with or without coexisting facial rosacea. Observation: A 58-year-old Hispanic man presented for evaluation of a one-month history of asymptomatic enlarged ears. He denied any triggers or history of repeated trauma to the affected area. His past medical history was non-contributory and notably negative for thyroid disease, dermatomyositis, systemic lupus erythematosus, angioedema or sarcoidosis. Physical examination was notable for bilateral diffuse auricular enlargement with mild- moderate edema and without associated overlying erythema, scale, erosion or induration. No paresthesia or dysesthesia was noted. His facial skin was devoid of any other dermatologic conditions. Importantly, he had no other signs of rosacea. The differential diagnosis included leprosy, sarcoidosis and malignancy, particularly angiosarcoma. A punch biopsy of the right ear lobule was notable for a superficial perivascular and perifollicular lymphoplasmacytic infiltrate and papillary dermal edema, consistent with rosacea.
    [Show full text]
  • Inhoudsopgave ­Officiële Orgaan Van De Nederlandse Vereniging Voor Dermatologie En Venereologie
    NEDERLANDS TIJDSCHRIFT VOOR DERMATOLOGIE EN VENEREOLOGIE | VOLUME 21 | NUMMER 02 | FEBRUARI 2011 61 Het Nederlands Tijdschrift voor Dermatologie en Venereologie is het InhoudsoPgave officiële orgaan van de Nederlandse Vereniging voor Dermatologie en Venereologie. Het NTvDV is vanaf 1 januari 2008 geïndiceerd in NVDV NASCHOLING - DERMATOLOGENDAGEN 2011 EMBase, de internationale wetenschappelijke database Programma 24 en 25 maart 2011 62 van Elsevier Science. Psoriasis genetics and clinical implications 68 Hoofdredactie Dr. P.G.M. van der Valk, hoofdredacteur Is psoriasis een afwijking van het verworven immuunsysteem? 70 79 artiKeLeN Psoriasis: een ziekte veroorzaakt door onze innate immuniteit? Dr. R.C. Beljaards, dr. J.J.E. van Everdingen, dr. C.J.W. van Ginkel, Psoriasis: een huidbarrièreziekte? 82 dr. M.J. Korstanje, prof. dr. A.P. Oranje, dr. R.I.F. van der Waal Kritische blik op psoriasis en cardiovasculaire ziekten 87 Leerzame zieKtegescHiedeNisseN Dr. R. van Doorn, dr. S. van Ruth, dr. M. Seyger, Stress, cortisol en psoriasis: als stress onder de huid gaat… 89 dr. J. Toonstra, dr. M. Vermeer Juveniele psoriasis 92 rubrieK dermatocHirurgie Een kritische beschouwing over de beschikbare behandelingen A.M. van Rengen, dr. J.V. Smit , dr. R.I.F. van der Waal van psoriasis 96 rubrieK referaat Dr. W.P. Arnold, dr. A.Y. Goedkoop, dr. E.M. van der Snoek, Kliniek, epidemiologie en pathogenese van acneïforme dr. T.J. Stoof, dr. H.B. Thio, dermatosen 101 rubrieK vereNigiNg Klinische presentaties en histopathologische kenmerken Dr. M.B. Crijns, dr. J.J.E. van Everdingen van acne vulgaris 102 rubrieK oNderzoeK vaN eigeN bodem Dr. H.J.
    [Show full text]
  • Dermatology 101: from Acne to Zebras and the Pearls in Between
    Dermatology 101: From Acne to Zebras and the Pearls in Between Dr Kyle Cullingham, BA, BSc, MSc, MD, FRCPC Dermatologist Skinsense Dermatology, Saskatoon,SK Assistant Professor University of Saskatchewan Disclosures Speaker: Dr Kyle Cullingham Relationships with commercial interests: Speakers Bureau/Honoraria: Abbvie, Allergan, Celgene, LEO Consulting Fees: Abbvie, Celgene, Galderma, Janssen, LEO, Novartis Conflict of Interest Declaration: Nothing to Disclose Presenter: Dr. Kyle Cullingham Title of Presentation:Dermatology for GPs I have no financial or personal relationship related to this presentation to disclose. Objectives Discuss some common dermatological concerns – focus on recognition, management, what’s new and pearls. Acne Clinical pearls Rosacea Psoriasis Eczema Interspersed with interesting real Dermatology cases with common pitfalls, red flags, or learning points. Time for questions/comments Acne disorder of the pilosebaceous unit affects certain areas of the body: face > trunk >> buttocks manifests during adolescence, but can occur at any stage of life comedones, papulopustules, nodules, cysts scarring can follow Epidemiology acne affects approximately 85% of adolescents onset during puberty (10-19 y/o); may appear after age 25 more severe in men higher incidence in caucasians and indigenous population inheritance: multifactorial; most patients with cystic acne have parental history of severe acne Pathogenesis Corneocyte Sebum Propionibacterium acnes Inflammatory cell Drugs Diet Recent JAAD review
    [Show full text]